Rovia Clinical Research Expands with New Site for Research
Rovia Clinical Research Expands with New Site for Research
Rovia Clinical Research is thrilled to share exciting news about the launch of a new clinical research site in collaboration with the Hattiesburg Clinic. This partnership is spearheaded by the esteemed principal investigator, Dr. Rambod Rouhbakhsh. The new site will pave the way for improved clinical research opportunities in the region.
About Hattiesburg Clinic
The Hattiesburg Clinic is the most significant privately-owned, multi-specialty health system in the area, boasting over 450 dedicated physicians and healthcare providers. This clinic serves more than 17 counties, employing around 2,000 staff members committed to patient care. Dr. Rouhbakhsh, a specialist in family, occupational, and environmental medicine, also directs the Family Medicine Residency Program at Forrest General Hospital, enhancing the quality of medical education and care.
The Significance of the Partnership
CEO Patricio Casillas from Rovia emphasized the importance of this new collaboration, stating that both the Hattiesburg Clinic and Dr. Rouhbakhsh hold significant respect both regionally and nationally. The partnership allows Rovia to establish a presence in an underserved area, which is crucial for expanding patient access to innovative treatments and clinical trials.
Rovia's Mission and Expertise
With over 18 years of experience in the realm of clinical research, Rovia Clinical Research operates a diverse and skilled network of clinical trial sites. The organization is recognized for its exceptional service, including efficient study start-ups, achieving enrollment targets, maintaining high patient retention rates, and ensuring the integrity of the collected data.
Network and Experience
Rovia operates through a hybrid model that includes both free-standing sites and physician-embedded locations. The organization manages 15 sites with a team of over 80 investigators, focusing on pivotal research areas such as endocrinology, obesity, cardiology, gastroenterology, neurology, ophthalmology, and infectious diseases. Rovia has consistently demonstrated its capability to enroll patients effectively, ensuring the highest standards for data quality and participant care.
Fostering Community Engagement
Rovia Clinical Research emphasizes optimizing trial management and enhancing patient engagement through its centralized teams and local expertise. By working collaboratively with various healthcare stakeholders and prioritizing access for underserved populations, Rovia is dedicated to advancing clinical trials that shape the future of medical research and drug development.
Conclusion and Future Directions
This strategic partnership marks an important step for Rovia as it continues to expand its influence in clinical research. The collaboration with the Hattiesburg Clinic will not only broaden the reach of innovative medical research but is also a testament to Rovia's commitment to improving healthcare access and outcomes for communities in need.
Frequently Asked Questions
What is the purpose of the new research site?
The new site aims to enhance clinical research opportunities and access to innovative treatments in the region.
Who is Dr. Rambod Rouhbakhsh?
Dr. Rouhbakhsh is the principal investigator at the new research site and is highly respected in family medicine.
What specialties does Rovia focus on?
Rovia specializes in areas such as endocrinology, cardiology, gastroenterology, and more.
How many locations does Rovia have?
Rovia operates a network of 15 sites with over 80 investigators across different specialties.
What is Rovia’s mission?
Rovia’s mission is to advance clinical research by prioritizing patient access and engagement in underserved communities.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
